EA201100764A1 - Твердая фармацевтическая композиция, содержащая по меньшей мере один стабилизирующий агент - Google Patents

Твердая фармацевтическая композиция, содержащая по меньшей мере один стабилизирующий агент

Info

Publication number
EA201100764A1
EA201100764A1 EA201100764A EA201100764A EA201100764A1 EA 201100764 A1 EA201100764 A1 EA 201100764A1 EA 201100764 A EA201100764 A EA 201100764A EA 201100764 A EA201100764 A EA 201100764A EA 201100764 A1 EA201100764 A1 EA 201100764A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
stabilizing agent
composition containing
solid pharmaceutical
metal hydroxides
Prior art date
Application number
EA201100764A
Other languages
English (en)
Other versions
EA024112B1 (ru
Inventor
Хемант Саграват
Анджали Р. Тендулкар
Ананди Кришнан
Весна Крошель
Тамара Герман
Кармен Зорко
Иванка Коленц
Сабина Трошт
Original Assignee
КРКА, д.д., НОВО МЕСТО
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by КРКА, д.д., НОВО МЕСТО filed Critical КРКА, д.д., НОВО МЕСТО
Publication of EA201100764A1 publication Critical patent/EA201100764A1/ru
Publication of EA024112B1 publication Critical patent/EA024112B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к твердой стабильной фармацевтической композиции, содержащей дезлоратадин и по меньшей мере один стабилизирующий агент, выбранный из группы состоящей из гидроксидов щелочного металла и гидроксидов щелочно-земельного металла, и гидроксида алюминия.
EA201100764A 2008-11-28 2009-11-27 Твердая фармацевтическая композиция дезлоратадина, содержащая стабилизирующий агент EA024112B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200800293 2008-11-28
PCT/EP2009/008467 WO2010060635A2 (en) 2008-11-28 2009-11-27 Solid pharmaceutical composition comprising at least one stabilizing agent

Publications (2)

Publication Number Publication Date
EA201100764A1 true EA201100764A1 (ru) 2012-01-30
EA024112B1 EA024112B1 (ru) 2016-08-31

Family

ID=42141661

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201100764A EA024112B1 (ru) 2008-11-28 2009-11-27 Твердая фармацевтическая композиция дезлоратадина, содержащая стабилизирующий агент

Country Status (4)

Country Link
EP (1) EP2379056B1 (ru)
EA (1) EA024112B1 (ru)
PL (1) PL2379056T3 (ru)
WO (1) WO2010060635A2 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2537169C1 (ru) * 2013-06-18 2014-12-27 Открытое Акционерное Общество "Татхимфармпрепараты" Фармацевтическая композиция, содержащая дезлоратадин (варианты)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201009396A2 (tr) * 2010-11-11 2012-05-21 Bi̇lgi̇ç Mahmut Desloratadin granüller

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119196A1 (en) * 2000-12-21 2002-08-29 Narendra Parikh Texture masked particles containing an active ingredient
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
EP1696881A2 (en) * 2003-12-23 2006-09-06 Sun Pharmaceutical Industries Limited Stable oral composition
WO2006011159A2 (en) 2004-06-21 2006-02-02 Torrent Pharmaceuticals Limited Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability
US9198862B2 (en) * 2005-07-22 2015-12-01 Rubicon Research Private Limited Dispersible tablet composition
US20070292510A1 (en) * 2006-06-19 2007-12-20 Hugh Huang Enteric coated particles containing an active ingredient
KR100855189B1 (ko) * 2006-07-12 2008-09-01 한올제약주식회사 구강 속붕해성 정제

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2537169C1 (ru) * 2013-06-18 2014-12-27 Открытое Акционерное Общество "Татхимфармпрепараты" Фармацевтическая композиция, содержащая дезлоратадин (варианты)

Also Published As

Publication number Publication date
PL2379056T3 (pl) 2016-10-31
WO2010060635A3 (en) 2011-04-14
EP2379056B1 (en) 2016-04-13
WO2010060635A2 (en) 2010-06-03
EA024112B1 (ru) 2016-08-31
EP2379056A2 (en) 2011-10-26

Similar Documents

Publication Publication Date Title
MX341825B (es) Compuestos de heteroarilo y usos de los mismos.
EA201290772A1 (ru) Новые формы ивабрадина гидрохлорида
MY153915A (en) Organic compounds
EA201291394A1 (ru) Твердые композиции
EA201171246A1 (ru) Содержащая трегалулозу композиция, ее получение и применение
EA201001710A2 (ru) Фармацевтическая композиция, которая содержит соль стронция, витамин d и циклодекстрин
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
UA107791C2 (en) Pesticidal compositions
MX2012007098A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
MX342683B (es) Analogos de ciclopamina.
BRPI1010768A2 (pt) composto, e, composição farmacêutica.
MX2012007161A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
IN2012DN01859A (ru)
WO2010048358A3 (en) Ethoxyphenylmethyl inhibitors of sglt2
EA201270590A1 (ru) Ингибиторы акт
NZ589517A (en) A pharmaceutical composition comprising rebamipide
DK2493312T3 (da) Farmaceutiske faststofsammensætninger, der indeholder en integrase- hæmmer
EA201101116A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
MX2013008500A (es) Disialillacto-n-tetraosa (dslnt) o variantes, isomeros, analogos y derivados de la misma para prevenir o inhibir la enfermedad del intestino.
EA201490761A1 (ru) R(+)-n-формилпропаргиламиноиндан
MX2012007365A (es) Composiciones farmaceuticas de liberacion lenta de iloperidona.
EA201001353A1 (ru) Гидробромид ивабрадина
CL2007002812A1 (es) Compuestos derivados de quinolina; composicion farmaceutica, utiles para inhibir el vih.
EA201590790A1 (ru) СТАБИЛЬНАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ PEG-ИНТЕРФЕРОНА АЛЬФА-2b

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU